Effective requesting method to detect fusion transcripts in chronic myelomonocytic leukemia RNA-seq.

IF 4 Q1 GENETICS & HEREDITY NAR Genomics and Bioinformatics Pub Date : 2024-09-24 eCollection Date: 2024-09-01 DOI:10.1093/nargab/lqae117
Florence Rufflé, Jérôme Reboul, Anthony Boureux, Benoit Guibert, Chloé Bessière, Raissa Silva, Eric Jourdan, Jean-Baptiste Gaillard, Anne Boland, Jean-François Deleuze, Catherine Sénamaud-Beaufort, Dorothée Selimoglu-Buet, Eric Solary, Nicolas Gilbert, Thérèse Commes
{"title":"Effective requesting method to detect fusion transcripts in chronic myelomonocytic leukemia RNA-seq.","authors":"Florence Rufflé, Jérôme Reboul, Anthony Boureux, Benoit Guibert, Chloé Bessière, Raissa Silva, Eric Jourdan, Jean-Baptiste Gaillard, Anne Boland, Jean-François Deleuze, Catherine Sénamaud-Beaufort, Dorothée Selimoglu-Buet, Eric Solary, Nicolas Gilbert, Thérèse Commes","doi":"10.1093/nargab/lqae117","DOIUrl":null,"url":null,"abstract":"<p><p>RNA sequencing technology combining short read and long read analysis can be used to detect chimeric RNAs in malignant cells. Here, we propose an integrated approach that uses k-mers to analyze indexed datasets. This approach is used to identify chimeric RNA in chronic myelomonocytic leukemia (CMML) cells, a myeloid malignancy that associates features of myelodysplastic and myeloproliferative neoplasms. In virtually every CMML patient, new generation sequencing identifies one or several somatic driver mutations, typically affecting epigenetic, splicing and signaling genes. In contrast, cytogenetic aberrations are currently detected in only one third of the cases. Nevertheless, chromosomal abnormalities contribute to patient stratification, some of them being associated with higher risk of poor outcome, e.g. through transformation into acute myeloid leukemia (AML). Our approach selects four chimeric RNAs that have been detected and validated in CMML cells. We further focus on <i>NRIP1-MIR99AHG</i>, as this fusion has also recently been detected in AML cells. We show that this fusion encodes three isoforms, including a novel one. Further studies will decipher the biological significance of such a fusion and its potential to improve disease stratification. Taken together, this report demonstrates the ability of a large-scale approach to detect chimeric RNAs in cancer cells.</p>","PeriodicalId":33994,"journal":{"name":"NAR Genomics and Bioinformatics","volume":"6 3","pages":"lqae117"},"PeriodicalIF":4.0000,"publicationDate":"2024-09-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11420675/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"NAR Genomics and Bioinformatics","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1093/nargab/lqae117","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/9/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"GENETICS & HEREDITY","Score":null,"Total":0}
引用次数: 0

Abstract

RNA sequencing technology combining short read and long read analysis can be used to detect chimeric RNAs in malignant cells. Here, we propose an integrated approach that uses k-mers to analyze indexed datasets. This approach is used to identify chimeric RNA in chronic myelomonocytic leukemia (CMML) cells, a myeloid malignancy that associates features of myelodysplastic and myeloproliferative neoplasms. In virtually every CMML patient, new generation sequencing identifies one or several somatic driver mutations, typically affecting epigenetic, splicing and signaling genes. In contrast, cytogenetic aberrations are currently detected in only one third of the cases. Nevertheless, chromosomal abnormalities contribute to patient stratification, some of them being associated with higher risk of poor outcome, e.g. through transformation into acute myeloid leukemia (AML). Our approach selects four chimeric RNAs that have been detected and validated in CMML cells. We further focus on NRIP1-MIR99AHG, as this fusion has also recently been detected in AML cells. We show that this fusion encodes three isoforms, including a novel one. Further studies will decipher the biological significance of such a fusion and its potential to improve disease stratification. Taken together, this report demonstrates the ability of a large-scale approach to detect chimeric RNAs in cancer cells.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
在慢性粒细胞白血病 RNA-seq 中检测融合转录本的有效请求方法。
结合短读和长读分析的 RNA 测序技术可用于检测恶性细胞中的嵌合 RNA。在这里,我们提出了一种使用 k-mers 分析索引数据集的综合方法。这种方法用于鉴定慢性粒细胞白血病(CMML)细胞中的嵌合 RNA,慢性粒细胞白血病是一种髓系恶性肿瘤,具有骨髓增生异常和骨髓增生性肿瘤的特征。在几乎所有 CMML 患者中,新一代测序技术都能发现一种或几种体细胞驱动基因突变,通常会影响表观遗传、剪接和信号转导基因。相比之下,目前只有三分之一的病例能检测到细胞遗传畸变。然而,染色体异常有助于对患者进行分层,其中一些异常与较高的不良预后风险有关,如转化为急性髓性白血病(AML)。我们的方法选择了已在 CMML 细胞中检测并验证的四种嵌合 RNA。我们进一步关注 NRIP1-MIR99AHG,因为最近在 AML 细胞中也检测到了这种融合。我们发现这种融合编码三种同工酶,其中包括一种新的同工酶。进一步的研究将揭示这种融合的生物学意义及其改善疾病分层的潜力。总之,本报告展示了大规模方法检测癌细胞中嵌合 RNA 的能力。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
8.00
自引率
2.20%
发文量
95
审稿时长
15 weeks
期刊最新文献
LoVis4u: a locus visualization tool for comparative genomics and coverage profiles. Comprehensive analysis of RNA-chromatin, RNA-, and DNA-protein interactions. Halfpipe: a tool for analyzing metabolic labeling RNA-seq data to quantify RNA half-lives. Current state and future prospects of Horizontal Gene Transfer detection. Advancing personalized cancer therapy: Onko_DrugCombScreen-a novel Shiny app for precision drug combination screening.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1